Showing 861 - 880 results of 24,146 for search '(( 50 ((mean decrease) OR (nn decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 0.96s Refine Results
  1. 861

    Inhibition of PSMA decreases pathologic angiogenesis in a mouse model of OIR. by Christina L. Grant (315488)

    Published 2013
    “…<p><b>A</b>) Wild type mice undergoing OIR were treated systemically with either a single dose of 100mg/kg 2-PMPA on P14 (n = 3, <b>center</b>) or three daily doses from P14 through P16 (n = 6, <b>right</b>), controls received vehicle (PBS, <b>left</b>). …”
  2. 862
  3. 863

    Opioid consumption data. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  4. 864

    Prescription data. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  5. 865

    Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  6. 866

    Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

    Published 2025
    “…Orthopaedic Surgery patients saw a mean 45% reduction in prescription size from 462 MMEs (range: 50–7200 MMEs) to 197 MMEs (range: 25–2400 MMEs) (p < .001), while General Surgery patients experienced a mean 38% reduction from 100 MMEs (range: 25–150 MMEs) to 60 MMEs (range: 25–150 MMEs) (p < .001). …”
  7. 867
  8. 868

    Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells. by Wilfried Jonkers (160931)

    Published 2014
    “…</p>3<p>Showed reduced expression in a <i>mak-2<sup>Q100G</sup></i> germlings treated with 1NM-PP1 (19).…”
  9. 869
  10. 870
  11. 871
  12. 872
  13. 873
  14. 874
  15. 875
  16. 876

    Trabectedin induced apoptosis in a dose-dependent manner as measured by the Muse™ Annexin V and Dead Cell assay. by Eda Acikgoz (816259)

    Published 2015
    “…Trabectedin was shown to induce apoptotic cell death in the cancer stem cells mainly with the increase in early apoptosis (green), cells and the apparent decreased in the percentage of live cells. Trabectedin also significantly induced the total apoptotic cells (yellow) in a dose-dependent manner. …”
  17. 877
  18. 878
  19. 879
  20. 880